Published in Presse Med on January 29, 2005
Clinical aspects and prognosis of Brugada syndrome in children. Circulation (2007) 2.29
Identification and distribution of interstitial Cajal cells in human pulmonary veins. Heart Rhythm (2008) 1.86
Muscarinic receptor upregulation in patients with myocardial infarction: a new paradigm. Circ Cardiovasc Imaging (2009) 1.42
Desmosomal gene analysis in arrhythmogenic right ventricular dysplasia/cardiomyopathy: spectrum of mutations and clinical impact in practice. Europace (2010) 1.40
Contributions of remote monitoring to the follow-up of implantable cardioverter-defibrillator leads under advisory. Eur Heart J (2010) 1.21
Clinical and mutational spectrum in a cohort of 105 unrelated patients with dilated cardiomyopathy. Eur J Med Genet (2011) 1.09
Toward personal eHealth in cardiology. Results from the EPI-MEDICS telemedicine project. J Electrocardiol (2005) 1.08
5-Fluorouracil-induced Tako-Tsubo-like syndrome. Pharmacotherapy (2011) 1.03
Prevalence and spectrum of mutations in a cohort of 192 unrelated patients with hypertrophic cardiomyopathy. Eur J Med Genet (2010) 1.00
New paradigms in telemedicine: ambient intelligence, wearable, pervasive and personalized. Stud Health Technol Inform (2004) 0.97
Evidence for genetic heterogeneity in Carvajal syndrome. Cell Tissue Res (2012) 0.95
Contribution of long-QT syndrome genetic variants in sudden infant death syndrome. Pediatr Cardiol (2009) 0.90
Sudden death of cardiac origin and psychotropic drugs. Front Pharmacol (2012) 0.89
Superoxide dismutase administration, a potential therapy against oxidative stress related diseases: several routes of supplementation and proposal of an original mechanism of action. Pharm Res (2013) 0.88
High accuracy of automatic detection of atrial fibrillation using wavelet transform of heart rate intervals. Pacing Clin Electrophysiol (2002) 0.86
Design and evaluation of a transesophageal HIFU probe for ultrasound-guided cardiac ablation: simulation of a HIFU mini-maze procedure and preliminary ex vivo trials. IEEE Trans Ultrason Ferroelectr Freq Control (2013) 0.84
Inflammation, a link between obesity and atrial fibrillation. Inflamm Res (2015) 0.83
[Atrial fibrillation following a rectal endoscopic injection using epiphedrine solution]. Gastroenterol Clin Biol (2002) 0.83
Long-standing bacteremia and endocarditis caused by Staphylococcus lugdunensis in a patient with an implantable cardioverter defibrillator. Clin Microbiol Infect (1997) 0.82
Right ventricular pump function after cardiac resynchronization therapy: a strain imaging study. Arch Cardiovasc Dis (2008) 0.82
Ivabradine induces an increase in ventricular fibrillation threshold during acute myocardial ischemia: an experimental study. J Cardiovasc Pharmacol (2008) 0.81
QT interval prolongation in future SIDS victims: a polysomnographic study. Sleep (2008) 0.81
A new C-terminal hERG mutation A915fs+47X associated with symptomatic LQT2 and auditory-trigger syncope. Heart Rhythm (2008) 0.80
Increased intracardiac vascular endothelial growth factor levels in patients with paroxysmal, but not persistent atrial fibrillation. Europace (2012) 0.80
Periatrial epicardial fat is associated with markers of endothelial dysfunction in patients with atrial fibrillation. PLoS One (2013) 0.80
Radiofrequency ablation of atrial fibrillation: the first 100 cases in Lyon. Int J Cardiol (2008) 0.80
Progressive endothelial damage revealed by multilevel von Willebrand factor plasma concentrations in atrial fibrillation patients. Europace (2013) 0.80
Ivabradine but not propranolol delays the time to onset of ischaemia-induced ventricular fibrillation by preserving myocardial metabolic energy status. Resuscitation (2012) 0.79
Cardiac retention of [11C]HED in genotyped long QT patients: a potential amplifier role for severity of the disease. Am J Physiol Heart Circ Physiol (2003) 0.79
French Society of Cardiology guidelines for cardiac rehabilitation in adults. Arch Cardiovasc Dis (2012) 0.79
Biophysical characterization of a new SCN5A mutation S1333Y in a SIDS infant linked to long QT syndrome. FEBS Lett (2009) 0.79
The effects of ropivacaine at clinically relevant doses on myocardial ischemia in pigs. J Anesth (2006) 0.79
Quantification of ventricular resynchronization reserve by radionuclide phase analysis in heart failure patients: a prospective long-term study. Circ Cardiovasc Imaging (2011) 0.78
Unprovoked atrial tachyarrhythmias in aging spontaneously hypertensive rats: the role of the autonomic nervous system. Am J Physiol Heart Circ Physiol (2012) 0.78
Thymic size and muscle mass of HIV-infected asymptomatic children from Burkina Faso. J Acquir Immune Defic Syndr (2002) 0.78
Heart rate reduction with ivabradine increases ischaemia-induced ventricular fibrillation threshold: role of myocyte structure and myocardial perfusion. Resuscitation (2011) 0.78
In-hospital heart rate turbulence and microvolt T-wave alternans abnormalities for prediction of early life-threatening ventricular arrhythmia after acute myocardial infarction. Ann Noninvasive Electrocardiol (2013) 0.78
Significance of serum troponin I elevation in patients with acute aortic dissection of the ascending aorta. Acta Cardiol (2005) 0.77
Cardiovascular disease in patients with spondyloarthropathies. Joint Bone Spine (2007) 0.77
Frequency of atrial tachyarrhythmias in patients treated by cardiac resynchronization (from the Prospective, Multicenter Mona Lisa Study). Am J Cardiol (2010) 0.76
Myocarditis and cardiac channelopathies: a deadly association? Int J Cardiol (2011) 0.76
150 microgram intracoronary adenosine bolus for accurate fractional flow reserve assessment of angiographically intermediate coronary stenosis. EuroIntervention (2005) 0.76
Scintigraphic spectrum of a patient population with suspected arrhythmogenic right ventricular dysplasia. Int J Cardiovasc Imaging (2011) 0.76
Predictors for short-term progressive heart failure death in New York Heart Association II patients implanted with a cardioverter defibrillator--the EVADEF study. Am Heart J (2010) 0.76
Response to letter by Robert M. Hamilton based on "Prophylactic radiofrequency ablation in asymptomatic patients with Wolff-Parkinson-White is not yet a good strategy: a decision analysis" by Chevalier et al. Circ Arrhythm Electrophysiol (2013) 0.75
High-tech catheter ablation: worth the cost? Arch Cardiovasc Dis (2009) 0.75
Scaring myocardial scars: new targets for the electrical fairy? J Am Coll Cardiol (2012) 0.75
Monitoring of heart rate variability in heart failure patients with cardiac resynchronisation therapy: interest of continuous and didactic algorithm. Int J Cardiol (2009) 0.75
Persistent abnormal intraventricular conduction after myocarditis revealed by recurrent syncopes. J Electrocardiol (2013) 0.75
Ropivacaine combined with various anti-arrhythmic drugs results in mild alterations in myocardial contractility in pigs. Can J Anaesth (2003) 0.75
Accelerated coronary atherosclerosis revealed by arrhythmogenic coronary spasm. Cardiology (2011) 0.75
Protective effects of ranolazine and propranolol, alone or combined, on the structural and functional alterations of cardiomyocyte mitochondria in a pig model of ischemia/reperfusion. Fundam Clin Pharmacol (2013) 0.75
Short-coupled variant of torsades de pointes with intractable ventricular fibrillation: lifesaving effect of cardiopulmonary bypass. J Cardiovasc Electrophysiol (2003) 0.75
Pulmonary vein hematoma after atrial fibrillation cryoablation: a new complication. Heart Rhythm (2012) 0.75
A heartless brain. Europace (2013) 0.75
Pneumomediastinum after implantable cardiac defibrillator implantation. Eur Heart J (2010) 0.75
Antihypertensive pharmacotherapy for prevention of sudden cardiac death in hypertensive individuals. Cochrane Database Syst Rev (2016) 0.75
Effects of amlodipine and perindoprilate on the structure and function of mitochondria in ventricular cardiomyocytes during ischemia-reperfusion in the pig. Fundam Clin Pharmacol (2014) 0.75
Risk of Sprint Fidelis defibrillator lead failure is highly dependent on age. Arch Cardiovasc Dis (2011) 0.75
[Intracardiac conduction disturbances]. Rev Prat (2012) 0.75
Beat-to-beat variations of the electrocardiogram in survivors of sudden death without structural heart disease. J Electrocardiol (2006) 0.75
Spatiotemporal electrocardiographic characterization of ventricular depolarization and repolarization abnormalities in long QT syndrome. J Electrocardiol (2007) 0.75
Athlete's heart or hypertrophic cardiomyopathy: usefulness of N-terminal pro-brain natriuretic peptide. Int J Cardiol (2008) 0.75
Therapeutic education in coronary heart disease: position paper from the Working Group of Exercise Rehabilitation and Sport (GERS) and the Therapeutic Education Commission of the French Society of Cardiology. Arch Cardiovasc Dis (2013) 0.75
Ventricular muscarinic receptor remodeling in patients with and without primary ventricular fibrillation. An imaging study. J Nucl Cardiol (2012) 0.75
The hemolytic-uremic syndrome. N Engl J Med (2002) 0.75
Wavelet transform for analysis of heart rate variability preceding ventricular arrhythmias in patients with ischemic heart disease. Int J Cardiol (2005) 0.75
Right superior vena cava drainage into the left atrium revealed by multiples strokes after pacemaker implantation. Heart Rhythm (2012) 0.75